Nasdaq · Healthcare
INSULET CORP (PODD)
As-reported financials and recent SEC filings for INSULET CORP, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$2.71B
Net income
$247.1M
Net margin
9.1%
Diluted EPS
$3.48
ROE
16.3%
P/E (TTM)
36.9×
Market cap
$10.96B
Debt / equity
0.6×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.71B | $2.07B | $1.70B | $1.31B | $1.10B |
| Gross profit | $1.94B | $1.45B | $1.16B | $805.6M | $752.1M |
| Operating income | $473.8M | $308.9M | $220.1M | $37.6M | $126.0M |
| Net income | $247.1M | $418.3M | $206.3M | $4.6M | $16.8M |
| Diluted EPS | $3.48 | $5.78 | $2.94 | $0.07 | $0.24 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-25
View on EDGAR →42026-06-04
View on EDGAR →42026-06-04
View on EDGAR →1442026-06-03
View on EDGAR →42026-06-03
View on EDGAR →SD2026-05-28
View on EDGAR →8-K2026-05-26
View on EDGAR →42026-05-21
View on EDGAR →Go deeper on PODD
Search INSULET CORP’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.